Founder Evidente. Top rated quantitative analyst, Evidente

Sam Ferraro

Founder Evidente. Top rated quantitative analyst

Evidente

Evidente is an independent financial education firm that delivers innovative financial advice to wholesale investors, including active long only funds, hedge funds, pension funds, and sovereign wealth funds, in Australia and globally.  Drawing on academic research in asset pricing, behavioural finance and portfolio construction, Evidente provides wholesale investors with commercial solutions to stock selection and asset allocation decisions across equities and other asset classes.

Macroeconomics

The March non-farm payrolls release confirmed that employment in the United States continues to expand but at a more moderate pace over the past three months.&nbsp;The Phillips curve has flattened since the financial crisis, which confirms that inflation has become less responsive to changes in the unemployment rate. A structurally lower participation rate associated with the demographics of ageing suggests that there is far more slack in the labour market than implied by the unemployment rate of 5.5%.&nbsp; The performance of premium rated growth stocks around the taper &lsquo;tantrum&rsquo; in May 2013 reveals just how sensitive these stocks are to the future course of US monetary policy. The worst four performing stocks among the ASX200 at the time were: CTD, DMP, IIN and REA, reflecting their long duration attributes. Discount rate shocks therefore represent a key risk for growth investors. But the recent moderation&nbsp;of US&nbsp;employment growth, still considerable slack in the US labour market, and little prospect that core inflation will move back to the Fed Reserve's 2% objective anytime soon, should buy more time for not just the Fed but also growth investors.

The March non-farm payrolls release confirmed that employment in the United States continues to expand but at a more moderate pace over the past three months.&nbsp;The Phillips curve has flattened since the financial crisis, which confirms that inflation has become less responsive to changes in the unemployment rate. A structurally lower participation rate associated with the demographics of ageing suggests that there is far more slack in the labour market than implied by the unemployment rate of 5.5%.&nbsp; The performance of premium rated growth stocks around the taper &lsquo;tantrum&rsquo; in May 2013 reveals just how sensitive these stocks are to the future course of US monetary policy. The worst four performing stocks among the ASX200 at the time were: CTD, DMP, IIN and REA, reflecting their long duration attributes. Discount rate shocks therefore represent a key risk for growth investors. But the recent moderation&nbsp;of US&nbsp;employment growth, still considerable slack in the US labour market, and little prospect that core inflation will move back to the Fed Reserve's 2% objective anytime soon, should buy more time for not just the Fed but also growth investors.

US employment growth moderates, buying the Fed and growth investors more time

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of ASX Stocks as of Sep 15th (reported today) which has an aggregated short interest worth USD0.0bn.</li>
<li>We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in NAB, Newcrest Mining, Pilbara Minerals, Perpetual, Sonic Healthcare, Metcash.</li>
</ul>


We analyzed the changes in short interest of ASX Stocks as of Sep 15th (reported today) which has an aggregated short interest worth USD0.0bn.
We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in NAB, Newcrest Mining, Pilbara Minerals, Perpetual, Sonic Healthcare, Metcash.


ASX Short Interest Weekly (Sep 15th): NAB, Newcrest Mining, Pilbara Minerals, Perpetual

Australia

Newcrest Mining Limited is a gold mining, exploration and production company. The Company is geographically focused in Australia, the Pacific region and Asia. Newcrest Mining operates projects within six provinces in four countries, focusing on the Cadia East and Lihir MOPU expansion projects and the Wafi Golpu and Namosi greenfield projects.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Newcrest Mining (NCM AU)

US employment growth moderates, buying the Fed and growth investors more time

The March non-farm payrolls release confirmed that employment in the United States continues to expand but at a more moderate pace over the past...

Sam Ferraro

ASX Short Interest Weekly (Sep 15th): NAB, Newcrest Mining, Pilbara Minerals, Perpetual

We analyzed ASX short interest report for the past week and highlight short interest changes in NAB, Newcrest Mining, Pilbara Minerals, Perpetual,...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)